Braxia Scientific Corp.
OTC: BRAXF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Peter Rizakos
- Headquarters
- Mississauga, Canada
- IPO year
- 2020
- Market cap
- $28.3K
- Website
- https://www.braxiascientific.com
Loading BRAXF…
Loading profile data…Frequently asked questions about BRAXF
What does Braxia Scientific Corp. (BRAXF) do?
Braxia Scientific Corp. functions as a medical research entity that also runs clinics, offering ketamine therapies to individuals suffering from depression and linked conditions. Beyond its clinical services, the company is actively engaged in discovering and bringing to market novel pharmaceutical compounds and innovative delivery methods. Leve...
Where does BRAXF trade?
Braxia Scientific Corp. (BRAXF) trades on the Other OTC.
What sector is BRAXF in?
Braxia Scientific Corp. (BRAXF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Braxia Scientific Corp.?
Peter Rizakos is the chief executive officer of Braxia Scientific Corp. (BRAXF).
Where is Braxia Scientific Corp. headquartered?
Braxia Scientific Corp. is headquartered in Canada.
Does BRAXF pay a dividend?
Braxia Scientific Corp. (BRAXF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BRAXF go public?
Braxia Scientific Corp. (BRAXF) completed its initial public offering in 2020.